Business Wire | Aug 31, 2020 12:01PM EDT

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Aimmune Therapeutics, Inc.

Aug. 31, 2020

NEW YORK--(BUSINESS WIRE)--Aug. 31, 2020--Rowley Law PLLC is investigating potential securities law violations by Aimmune Therapeutics, Inc. (NASDAQ: AIMT) and its board of directors concerning the proposed acquisition of the company by Nestl S.A. Stockholders will receive $34.50 in cash for each share of Aimmune Therapeutics stock that they hold. The transaction is valued at approximately $2.6 billion and is expected to close in the fourth quarter of 2020.

If you are a stockholder of Aimmune Therapeutics, Inc. and are interested in obtaining additional information regarding this investigation, please visit us at: http://www.rowleylawpllc.com/investigation/aimt/. You may also contact Shane Rowley, Esq. at Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at info@rowleylawpllc.com, or by telephone at 914-400-1920 or 844-400-4643 (toll-free).

Rowley Law PLLC represents shareholders nationwide in class actions and derivative lawsuits in complex corporate litigation. For more information about the firm and its attorneys, please visit http://www.rowleylawpllc.com.

Attorney Advertising. Prior results do not guarantee a similar outcome.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200831005562/en/

CONTACT: Shane Rowley, Esq. Rowley Law PLLC info@rowleylawpllc.com 914-400-1920 or 844-400-4643 (toll-free)